Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 4, 2003
Grant Date -
Mar 28, 2002
app pub date -
Aug 27, 2001
filing date -
Jan 13, 1995
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The application is directed to the treatment of neoplastic diseases or conditions by administering R(-) desmethylselegiline, S(+) desmethylselegiline, or a combination of the two. Neoplastic diseases and conditions responsive to R(-) desmethylselegiline and/or S(+) desmethylselegiline include both malignant and benign neoplasms.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully